Publication | Closed Access
Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice
69
Citations
34
References
2020
Year
Intravitreal BevacizumabPatient SafetyRoutine Clinical PracticePharmacotherapySystemic Adverse EventsMedicineRheumatoid ArthritisAnesthesiology
| Year | Citations | |
|---|---|---|
Page 1
Page 1